Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
DNA Stock | USD 14.73 1.18 8.71% |
About 62% of Ginkgo Bioworks' investor base is looking to short. The analysis of the overall investor sentiment regarding Ginkgo Bioworks Holdings suggests that many traders are alarmed. The current market sentiment, together with Ginkgo Bioworks' historical and current headlines, can help investors time the market. In addition, many technical investors use Ginkgo Bioworks Holdings stock news signals to limit their universe of possible portfolio assets.
Ginkgo |
PRNewswire -- Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced the completion of the...
Read at prnewswire.com
![]() |
Ginkgo Bioworks Holdings Current Investor Sentiment
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ginkgo Bioworks' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ginkgo Bioworks Holdings.
News SentimentNeutral | Hype SentimentBullish | Insider SentimentDisposing |
Ginkgo Bioworks Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ginkgo Bioworks can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ginkgo Bioworks Holdings Historical Investor Sentiment
Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks news discussions. The higher the estimate score, the more favorable the investor's outlook on Ginkgo Bioworks.
Ginkgo Bioworks Maximum Pain Price Across March 21st 2025 Option Contracts
Ginkgo Bioworks' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Ginkgo Bioworks close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Ginkgo Bioworks' options.
Ginkgo Bioworks Fundamental Analysis
We analyze Ginkgo Bioworks' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ginkgo Bioworks using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ginkgo Bioworks based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Ginkgo Bioworks is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Ginkgo Bioworks Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ginkgo Bioworks stock to make a market-neutral strategy. Peer analysis of Ginkgo Bioworks could also be used in its relative valuation, which is a method of valuing Ginkgo Bioworks by comparing valuation metrics with similar companies.
Peers
Ginkgo Bioworks Related Equities
ELEV | Elevation Oncology | 1.52 | ||||
ENVB | Enveric Biosciences | 0.63 | ||||
HEPA | Hepion Pharmaceuticals | 10.00 | ||||
OCEA | Ocean Biomedical | 13.33 |
Complementary Tools for Ginkgo Stock analysis
When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |